Demonstrates that in the human right atrium, ETA receptors couple to two distinct signal-transduction pathways: inositol phosphate formation and adenylate cyclase inhibition.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for dual ETA signaling in atrium; leaves open translation to human disease or therapy.
To study signal transduction pathways of endothelin (ET) in human heart, we assessed, in isolated human right atria, the effects of ET-1 and ET-3 on inositol phosphate (IP) formation and on the adenylate cyclase/cyclic AMP system. In right atrial slices, ET-1 (10(-10)-10(-6)M) concentration-dependently increased [3H]IP accumulation and decreased 10-microM isoprenaline-induced or 1-microM forskolin-induced increases in cyclic AMP content. ET-3 was approximately 100 times less potent. The cyclic AMP-decreasing effect of ET-1 (10(-11)-10(-6)M) could also be demonstrated directly in adenylate cyclase assays in right atrial membranes; again, ET-3 was approximately 100 times less potent. We conclude that in human right atrium, ETA receptors couple to two different signal-transduction pathways: IP formation and inhibition of adenylate cyclase.
No takes yet. Share an insight, caveat, or question.
Vogelsang et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: